Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

I C U Medical Inc (ICUI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,656,885
  • Shares Outstanding, K 20,470
  • Annual Sales, $ 1,293 M
  • Annual Income, $ 68,640 K
  • 36-Month Beta 0.41
  • Price/Sales 4.34
  • Price/Cash Flow 29.17
  • Price/Book 4.26

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate 1.26
  • Number of Estimates 2
  • High Estimate 1.43
  • Low Estimate 1.10
  • Prior Year 0.01
  • Growth Rate Est. (year over year) +12,500.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
256.70 +7.65%
on 10/10/18
286.45 -3.53%
on 09/28/18
+4.20 (+1.54%)
since 09/17/18
3-Month
256.70 +7.65%
on 10/10/18
321.70 -14.10%
on 08/10/18
-20.20 (-6.81%)
since 07/17/18
52-Week
180.45 +53.14%
on 11/09/17
321.70 -14.10%
on 08/10/18
+88.60 (+47.19%)
since 10/17/17

Most Recent Stories

More News
Imprivata Enters into Agreement with ICU Medical to Improve Security for Infusion Pumps

Imprivata(R), the healthcare IT security company, today announced a new collaboration with ICU Medical Inc., a leader in the development, manufacture, and sale of innovative medical products used in infusion...

ICUI : 276.35 (+0.74%)
TG Therapeutics (TGTX) in Focus: Stock Moves 8.6% Higher

TG Therapeutics (TGTX) shares rose nearly 9% in the last trading session, amid huge volumes.

TGTX : 5.70 (-1.04%)
ICUI : 276.35 (+0.74%)
The Infusion Therapy Devices Market in China (2018-2024): Units Sold, Average Selling Prices, Market Values, Shares, and Product Pipeline - ResearchAndMarkets.com

Companies Featured

ICUI : 276.35 (+0.74%)
ICU Medical (ICUI) Enters Oversold Territory

ICU Medical, Inc. (ICUI) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock

ICUI : 276.35 (+0.74%)
3 Top Stocks From the Booming US Medical Products Industry

The U.S. Medical Products industry is sturdy on solid focus on technological advancement.

SRDX : 66.05 (+0.59%)
ATHN : 125.64 (+0.38%)
VEEV : 95.54 (+0.25%)
ICUI : 276.35 (+0.74%)
QDEL : 68.03 (+0.38%)
Medical - Products Stock Outlook: Short-Term Pain Inevitable

Medical - Products Stock Outlook: Short-Term Pain Inevitable

ABT : 70.23 (-1.01%)
SRDX : 66.05 (+0.59%)
ICUI : 276.35 (+0.74%)
QDEL : 68.03 (+0.38%)
ICU Medical, Inc. to Present at the 2018 Morgan Stanley Global Healthcare Conference

ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced that Company management...

MS : 47.19 (+2.72%)
ICUI : 276.35 (+0.74%)
Baxter's Actifuse Flow Bone Graft Substitute Gets FDA Nod

The latest FDA approval for Baxter's (BAX) Actifuse Flow bone graft is likely to boost its Advanced Surgery segment.

SRDX : 66.05 (+0.59%)
EGRX : 61.03 (-1.55%)
BAX : 72.44 (+0.95%)
ICUI : 276.35 (+0.74%)
Zacks.com featured highlights include: ICU Medical, FTI, Aspen, Old Dominion and Illumina

Zacks.com featured highlights include: ICU Medical, FTI, Aspen, Old Dominion and Illumina

FCN : 68.64 (-0.90%)
ILMN : 328.96 (+0.73%)
AZPN : 104.05 (+0.04%)
ICUI : 276.35 (+0.74%)
ODFL : 135.61 (-2.44%)
5 Momentum Stocks Worth Investing in via Driehaus Strategy

Using the "buy high and sell higher" rule, Richard Herman Driehaus has created an investment approach.

FCN : 68.64 (-0.90%)
ILMN : 328.96 (+0.73%)
AZPN : 104.05 (+0.04%)
ICUI : 276.35 (+0.74%)
ODFL : 135.61 (-2.44%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum. Long term indicators fully support a continuation of the trend.

See More Share

Trade ICUI with:

Business Summary

ICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. They are one of the world's leading pure-play infusion therapy companies, with global operations and a wide-ranging product portfolio that includes IV solutions,...

See More

Key Turning Points

2nd Resistance Point 281.90
1st Resistance Point 279.13
Last Price 276.35
1st Support Level 272.40
2nd Support Level 268.44

See More

52-Week High 321.70
Last Price 276.35
Fibonacci 61.8% 267.74
Fibonacci 50% 251.08
Fibonacci 38.2% 234.41
52-Week Low 180.45

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar